NCT03925129

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation

A Randomized, Placebo Controlled Trial of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Planned Parenthood of Greater New York · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is a double-blinded, randomized, placebo-controlled trial evaluating the use of High-frequency Transcutaneous Electrical Nerve Stimulation (HfTENS) compared to sham TENS for pain control during medication abortion with mifepristone and misoprostol through 70 days' gestation.

Conditions

• Abortion in First Trimester

Interventions

Type	Name	Description
DEVICE	high frequency TENS treatment	Treatment with high frequency for minimum of 1 hour after misoprostol administration
DEVICE	Sham TENS treatment	Treatment with sham TENS device for minimum of 1 hour after misoprostol administration

Timeline

• Start date: 2019-06-11
• Primary completion: 2020-03-06
• Completion: 2020-03-13
• First posted: 2019-04-24
• Last updated: 2021-04-22

Locations

1 site across 1 country: United States